Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics

Medtronic is expected to report Q1 earnings of $1.39 per share, up 10.3% year-over-year, with revenues projected at $9.47 billion, representing 10.4% growth. Analysts forecast broad-based growth across most business segments, including Cardiovascular (+15.2%), Diabetes (+15.1%), and Neuroscience (+10.7%). The stock has outperformed the S&P 500 with +5.1% returns over the past month and carries a Zacks Rank #3 (Hold) rating.